Back to today’s briefing

Story perspectives

Revolutionary Advances in Treating Rare Genetic Disorders Unveiled

7/4/2025

30 3

Summary

Story summary

Groundbreaking strides in treating rare genetic disorders are unfolding! The Wyss Institute has pinpointed vorinostat as a potential Rett syndrome therapy, while researchers at the University at Buffalo discovered a link between KMT2D gene deactivation and enamel defects. Meanwhile, Tohoku University’s MA-5 drug offers hope for Barth syndrome, and the University of Miami is turbocharging the GENA platform for quicker genetic disease diagnoses.

1 of 1

Story summary

Groundbreaking strides in treating rare genetic disorders are unfolding! The Wyss Institute has pinpointed vorinostat as a potential Rett syndrome therapy, while researchers at the University at Buffalo discovered a link between KMT2D gene deactivation and enamel defects. Meanwhile, Tohoku University’s MA-5 drug offers hope for Barth syndrome, and the University of Miami is turbocharging the GENA platform for quicker genetic disease diagnoses.